• Strongest year on record with $520M in new contracts, including largest deal with Trinity Health
• Cloud adoption driving streamlined implementations and increased scalability, security, and cost-effectiveness
• Cardiology and other 'ologies' are strategic focus areas, leveraging unified Visage 7 platform

In this interview, Pro Medicus CEO Dr. Sam Hupert provides an overview of the company's FY25 results, which he describes as 'more than solid'. Key highlights include securing seven new contracts valued at a minimum of AUD $520M, including the largest deal to date with Trinity Health. The company also had two clients upgrade to Visage 7 Open Archive, adding $39M, and two major renewals totaling $130M. Hupert notes that the majority of the new contract revenue is still ahead, with over 98% to be realized in FY26 and beyond. He attributes the strong performance to the company's cloud-based platform, which is now the preferred choice for new clients due to its scalability, security, and cost-effectiveness. Pro Medicus has also made progress in expanding into new areas like cardiology, which was a key component of the UC Health contract. Hupert sees cardiology and other 'ologies' as important growth drivers going forward, as the company can leverage its unified Visage 7 platform. On the financial front, margins have continued to improve, reaching 74% at the EBIT level, and Hupert believes there is potential for further margin expansion. The company's implementation processes have also become more streamlined, allowing it to deploy solutions faster than competitors. Pro Medicus continues to invest in AI capabilities, including a research collaboration with UCSF and a licensing agreement with NYU Langone. With a strong pipeline and $210 million in cash reserves, the company is well-positioned to drive continued growth and returns for shareholders.

Pro Medicus expects its recently won contracts, including the $520M in new deals and the $948M in current forward contracted revenue, to start contributing significantly to revenue and profitability in FY26 and beyond. The company sees potential for further margin expansion from the incremental revenue of these new contracts.

Pro Medicus is focused on continued market share growth, leveraging its leading-edge, cloud-based Visage 7 platform and streamlined implementation capabilities. The company sees significant opportunities in expanding into new areas like cardiology and other medical specialties, further strengthening its position as a comprehensive, unified solution provider for healthcare enterprises.